Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders

Palmitoylethanolamide (PEA) is an endocannabinoid-like bioactive lipid mediator belonging to the family of N-acylethanolamines, most abundantly found in peanuts and egg yolk. When the gastrointestinal (GI) effects of PEA are discussed, it must be pointed out that it affects intestinal motility but a...

Full description

Saved in:
Bibliographic Details
Main Authors: Marija Branković (Author), Tijana Gmizić (Author), Marija Dukić (Author), Marija Zdravković (Author), Branislava Daskalović (Author), Davor Mrda (Author), Novica Nikolić (Author), Milica Brajković (Author), Milan Gojgić (Author), Jovana Lalatović (Author), Đorđe Kralj (Author), Ivana Pantić (Author), Marko Vojnović (Author), Tamara Milovanović (Author), Siniša Đurašević (Author), Zoran Todorović (Author)
Format: Book
Published: MDPI AG, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_cb15ecf453c049149968b0cf482f3468
042 |a dc 
100 1 0 |a Marija Branković  |e author 
700 1 0 |a Tijana Gmizić  |e author 
700 1 0 |a Marija Dukić  |e author 
700 1 0 |a Marija Zdravković  |e author 
700 1 0 |a Branislava Daskalović  |e author 
700 1 0 |a Davor Mrda  |e author 
700 1 0 |a Novica Nikolić  |e author 
700 1 0 |a Milica Brajković  |e author 
700 1 0 |a Milan Gojgić  |e author 
700 1 0 |a Jovana Lalatović  |e author 
700 1 0 |a Đorđe Kralj  |e author 
700 1 0 |a Ivana Pantić  |e author 
700 1 0 |a Marko Vojnović  |e author 
700 1 0 |a Tamara Milovanović  |e author 
700 1 0 |a Siniša Đurašević  |e author 
700 1 0 |a Zoran Todorović  |e author 
245 0 0 |a Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders 
260 |b MDPI AG,   |c 2024-05-01T00:00:00Z. 
500 |a 10.3390/antiox13050600 
500 |a 2076-3921 
520 |a Palmitoylethanolamide (PEA) is an endocannabinoid-like bioactive lipid mediator belonging to the family of N-acylethanolamines, most abundantly found in peanuts and egg yolk. When the gastrointestinal (GI) effects of PEA are discussed, it must be pointed out that it affects intestinal motility but also modulates gut microbiota. This is due to anti-inflammatory, antioxidant, analgesic, antimicrobial, and immunomodulatory features. Additionally, PEA has shown beneficial effects in several GI diseases, particularly irritable bowel syndrome and inflammatory bowel diseases, as various studies have shown, and it is important to emphasize its relative lack of toxicity, even at high dosages. Unfortunately, there is not enough endogenous PEA to treat disturbed gut homeostasis, even though it is produced in the GI tract in response to inflammatory stimuli, so exogenous intake is mandatory to achieve homeostasis. Intake of PEA could be through animal and/or vegetable food, but bearing in mind that a high dosage is needed to achieve a therapeutic effect, it must be compensated through dietary supplements. There are still open questions pending to be answered, so further studies investigating PEA's effects and mechanisms of action, especially in humans, are crucial to implementing PEA in everyday clinical practice. 
546 |a EN 
690 |a palmitoylethanolamide 
690 |a gastrointestinal tract 
690 |a anti-inflammatory 
690 |a antioxidants 
690 |a IBS 
690 |a IBD 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antioxidants, Vol 13, Iss 5, p 600 (2024) 
787 0 |n https://www.mdpi.com/2076-3921/13/5/600 
787 0 |n https://doaj.org/toc/2076-3921 
856 4 1 |u https://doaj.org/article/cb15ecf453c049149968b0cf482f3468  |z Connect to this object online.